A carregar...
Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China
BACKGROUND: Colistin is being administered as last-line therapy for patients that have failed to respond to other available antibiotics that are active against Escherichia coli. The underlying mechanisms of colistin resistance and heteroresistance remain largely uncharacterized. The present study in...
Na minha lista:
| Publicado no: | Infect Drug Resist |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7553605/ https://ncbi.nlm.nih.gov/pubmed/33116674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S273784 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|